Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers - (2024)

Review: Opportunities and barriers for omics-based biomarker discovery in steatotic liver diseases - (2024)

Modeling microbiota-associated human diseases: from minimal models to complex systems - (2022)

Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy - (2023)

Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective - (2023)

Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies - (2023)

The person-to-person transmission landscape of the gut and oral microbiomes - (2023)

The non-selective Rho-kinase inhibitors Y-27632 and Y-33075 decrease contraction but increase migration in murine and human hepatic stellate cells - (2023)

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis - (2022)

Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS - (2022)